Nondetectable prostate cancer in radical prostatectomy specimens

• Published in: Orvosi hetilap Vol. 153; no. 3; p. 113
• Main Authors: Murányi, Mihály, Morshed, Ali Salah, Benyó, Mátyás, Tóth, Csaba, Flaskó, Tibor
• Format: Journal Article
• Language: Hungarian
• Published: Hungary 22.01.2012
• Subjects: Aged; Aged, 80 and over; Biomarkers, Tumor - blood; Humans; Hungary; Male; Middle Aged; Neoplasm Staging; Prostate-Specific Antigen - blood; Prostatectomy - methods; Prostatectomy - statistics & numerical data; Prostatic Hyperplasia - diagnosis; Prostatic Hyperplasia - surgery; Prostatic Neoplasms - diagnosis; Prostatic Neoplasms - immunology; Prostatic Neoplasms - pathology; Prostatic Neoplasms - surgery; Retrospective Studies; Hungary
• ISSN: 0030-6002
• DOI: 10.1556/OH.2012.29285

Since the widespread use of prostate-specific antigen, early diagnosis of prostate cancer at an early stage has been increased. Consequently, a greater frequency of low-volume disease or no tumor has been found in radical prostatectomy specimen. In the present study authors analyzed patients classified as pT0 after radical prostatectomy at their center. 1134 radical prostatectomies were evaluated retrospectively at the author's center between 1996 and 2010. If there was no evidence of prostate cancer in the specimen, patient was staged as pT0. Patients were divided into two groups: received neoadjuvant hormonal therapy or not. Overall 32 (2.8%) patients were staged as pT0. The rate of pT0 staging was 9.3% and 1.2% in the hormonally treated group and non-hormonally treated group. False-positive prostate biopsy was found in 2 cases. The rate of pT0 staging was higher in patients with incidental prostate cancer, low Gleason score and enlarged prostate. Biochemical relapse was observed in 3 pT0 patients in the hormonally treated group, among them there was one clinical relapse. In non-hormonally treated group no recurrence was detected. The rate of pT0 staging was higher in the hormonally treated group. Because of biochemical and clinical relapse despite vanishing prostate cancer phenomenon, these cases are considered not to be true pT0. On the basis of present study and other reports the rate of pT0 staging is about one percentage in non-hormonally treated patients. Prognosis of these patients is excellent.